Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Apr;50(4):332-342.
doi: 10.1111/joor.13414. Epub 2023 Jan 24.

Nocebo response in dentistry: A systematic review and meta-analysis of adverse events in analgesic trials of third molar removal

Takeshi Watanabe  1   2 , Mette Sieg  1 , Sigrid Juhl Lunde  1 , Mads Persson  1 , Pankaj Taneja  3   4   5 , Lene Baad-Hansen  4   5   6 , Maria Pigg  4   5   7 , Lene Vase  1
Affiliations
Meta-Analysis

Nocebo response in dentistry: A systematic review and meta-analysis of adverse events in analgesic trials of third molar removal

Takeshi Watanabe et al. J Oral Rehabil. 2023 Apr.

Abstract

Background: The nocebo response refers to the phenomenon where non-specific factors, including negative verbal suggestion and treatment expectations, cause adverse events (AE) following a placebo treatment. Non-specific factors are also likely to influence AE occurrence following administration of active pharmacological treatments.

Objective: This meta-analysis aimed to estimate the nocebo response in dentistry by assessing the AEs prevalence in placebo- and active arms of randomised controlled trials (RCTs) assessing analgesic treatment following third molar (M3) surgery.

Methods: A systematic search was performed in PubMed, Embase, Scopus, Web of Science and the Cochrane Central Register of Controlled Trials. Eligible studies had to report the number of patients experiencing at least one drug-related AE (patients with AE ≥ 1) separately for the active and placebo arms. The proportion of patients with AE ≥ 1 and drug-related dropouts were pooled, and risk differences (RDs) between patients in the placebo- and active arm were calculated.

Results: In 50 independent RCTs of 47 identified articles, the pooled rates of patients with AE ≥ 1 were 22.8% in the placebo arm and 20.6% in the active arm. The pooled rates of drug-related dropout were 0.24% in the placebo arm and 0.08% in the active arm. There were no significant RDs in patients with AE ≥ 1 and drug-related dropouts.

Conclusion: These results show that patients in the placebo arm reported AEs to the same extent as patients receiving active treatment, suggesting that most AEs in analgesic medication following M3 surgery may be attributed to the nocebo phenomenon.

Keywords: analgesics; long term adverse effects; nocebo effect; oral surgery; pain; third molar.

PubMed Disclaimer

References

REFERENCES

    1. Howick J, Webster R, Kirby N, Hood K. Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials. Trials. 2018;19(1):674. doi:10.1186/s13063-018-3042-4
    1. Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol. 2008;59:565-590. doi:10.1146/annurev.psych.59.113006.095941
    1. Mahr A, Golmard C, Pham E, Iordache L, Deville L, Faure P. Types, frequencies, and burden of nonspecific adverse events of drugs: analysis of randomized placebo-controlled clinical trials. Pharmacoepidemiol Drug Saf. 2017;26(7):731-741. doi:10.1002/pds.4169
    1. Webster RK, Rubin GJ. Influencing side-effects to medicinal treatments: a systematic review of brief psychological interventions. Front Psych. 2018;9:775. doi:10.3389/fpsyt.2018.00775
    1. Evers AWM, Colloca L, Blease C, et al. Implications of placebo and nocebo effects for clinical practice: expert consensus. Psychother Psychosom. 2018;87(4):204-210. doi:10.1159/000490354

LinkOut - more resources